-
Cowen and Company 38th Annual Health Care Conference
Upcoming events
Webcast - Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US
09:00 CET
January 21, 2022, Oncopeptides announced that the Company has contacted the US Food and Drug Administration and rescinded the October 22, 2021, letter requesting voluntary withdrawal of the NDA of Pepaxto® in the US. Investors, financial analysts and media are invited to participate in a webcast with a Q&A session on January 24, 2022, at 09:00 (CET).